New Probiotic Karkuma BioComfort Shows Promise for GERD and IBS Relief

A new probiotic food product, Karkuma BioComfort, has shown promising results in easing symptoms of common digestive disorders. Researchers presented findings at a recent event, suggesting the blend of Bacillus coagulans and prebiotic FOS could help manage GERD and IBS. The discussion took place at the Centre for Advanced Research in Sciences on Dhaka University’s campus.

The clinical trial focused on Karkuma BioComfort, a product designed to support gut health. Participants reported a noticeable reduction in symptoms linked to gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS). While no formal publication of the trial exists, the results were shared during a dedicated seminar.

The event was organised by the department of food technology and nutritional science at Mawlana Bhashani Science and Technology University. Speakers explored the broader role of probiotics in improving human health, particularly their increasing use in functional foods. They also addressed the regulatory challenges surrounding probiotic-based products. Attendees highlighted a global trend toward probiotic-rich diets as a way to lower the risk of long-term health issues. The discussion emphasised how such foods could play a key part in preventive healthcare strategies.

The findings on Karkuma BioComfort add to growing evidence supporting probiotics for digestive health. Researchers stressed the need for further studies to confirm the results and establish clear guidelines. The event underscored the potential of functional foods in managing chronic conditions like GERD and IBS.